These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
9. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934 [TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy. Collen D; Lijnen HR Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640 [No Abstract] [Full Text] [Related]
12. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents]. Samama M; Horellou MH; Nguyen G; Conard J Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199 [No Abstract] [Full Text] [Related]
13. Biochemical and pharmacologic comparison of thrombolytic agents. Stringer KA Pharmacotherapy; 1996; 16(5 Pt 2):119S-126S. PubMed ID: 8888099 [TBL] [Abstract][Full Text] [Related]
14. Current state of thrombolytic therapy. Vorchheimer DA Curr Cardiol Rep; 1999 Sep; 1(3):212-20. PubMed ID: 10980844 [TBL] [Abstract][Full Text] [Related]